The application provides application of phenolic compounds and / or pharmaceutically acceptable salts thereof in preparation of drugs for treating
breast cancer, a pharmaceutical composition, and relates to the technical field of biological medicines.The application of phenolic compounds and / or pharmaceutically acceptable salts thereof in preparation of drugs for treating
breast cancer, wherein the phenolic compounds include compound 1 and / or compound 2.The compound 1 (arnebidin) and the compound 2 ((+)-(R)-de-O-methyllasiodiplodin) used in the application have good inhibiting effects on human triple-negative
breast cancer MDA-MB-231
cell strains, the IC 50 value of the compound 1 is 1.16 muM, the IC 50 value of the compound 2 is 0.68 muM, which provides a new choice for developing a therapeutic
drug for triple-negative breast
cancer, and has a good application prospect in preparation of drugs for treating breast
cancer, in particular, drugs for treating triple-negative breast
cancer.